CliffBio

United Laboratories

Patent cliffs & loss of exclusivity

23 upcoming patent cliffs

DrugIngredientTypeCliff
  1. REMODULINTREPROSTINILSmall mol.Dec 2028
  2. REMODULINTREPROSTINILSmall mol.Dec 2028
  3. REMODULINTREPROSTINILSmall mol.Dec 2028
  4. REMODULINTREPROSTINILSmall mol.Dec 2028
  5. REMODULINTREPROSTINILSmall mol.Mar 2029
  6. REMODULINTREPROSTINILSmall mol.Mar 2029
  7. REMODULINTREPROSTINILSmall mol.Mar 2029
  8. REMODULINTREPROSTINILSmall mol.Mar 2029
  9. REMODULINTREPROSTINILSmall mol.Mar 2029
  10. REMODULINTREPROSTINILSmall mol.Mar 2029
  11. REMODULINTREPROSTINILSmall mol.Mar 2029
  12. REMODULINTREPROSTINILSmall mol.Mar 2029
  13. ORENITRAMTREPROSTINIL DIOLAMINESmall mol.Aug 2031
  14. ORENITRAMTREPROSTINIL DIOLAMINESmall mol.Aug 2031
  15. ORENITRAMTREPROSTINIL DIOLAMINESmall mol.Aug 2031
  16. ORENITRAMTREPROSTINIL DIOLAMINESmall mol.Aug 2031
  17. ORENITRAMTREPROSTINIL DIOLAMINESmall mol.Aug 2031
  18. TYVASO DPITREPROSTINILSmall mol.Feb 2042
  19. TYVASO DPITREPROSTINILSmall mol.Feb 2042
  20. TYVASO DPITREPROSTINILSmall mol.Feb 2042
  21. TYVASO DPITREPROSTINILSmall mol.Feb 2042
  22. TYVASO DPITREPROSTINILSmall mol.Feb 2042
  23. TYVASOTREPROSTINILSmall mol.Feb 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Not found